Inocucor Technologies Inc., an agriculture biotech company that produces biological accelerators for farmers, has received a notice of allowance from the U.S. Patent and Trademark Office for its patent application to protect Inocucor consortia and unique microbial products that accelerate plant growth and enhance yields on farms and in greenhouses.
This initial patent relates to Inocucor’s live IN-M1 microbial consortium and its fermentation byproducts, which are the basis of the formulation for Inocucor Garden Solution, the company’s first-generation growth-accelerator product. Garden Solution is formulated to naturally sustain robust plant growth, increase plant vigor and actively build a friable and rich soil, improving the health of the entire phyto-microbiome.
The patent applies to each of the individual Inocul-M microorganisms characterized by Inocucor and in other task-specific live consortia like IN-M1. Also protected are the biological ingredients produced during Inocucor’s multi-species manufacturing process.
More information is available here: http://inocucor.com/press-release/inocucor-technologies-receives-groundbreaking-u-s-patent-proprietary-biological-processes-stimulate-plant-growth
